Difference between revisions of "Hepatocyte nuclear factor-1beta"
Jump to navigation
Jump to search
(tweak) |
|||
| Line 3: | Line 3: | ||
==Positive== | ==Positive== | ||
*[[Clear cell carcinoma of the ovary]]. | *[[Clear cell carcinoma of the ovary]]. | ||
*[[Clear cell renal cell carcinoma]].<ref name=pmid26574638>{{cite journal | | *[[Clear cell renal cell carcinoma]].<ref name=pmid26574638>{{cite journal |authors=Hanley KZ, Cohen C, Osunkoya AO |title=Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall |journal=Appl. Immunohistochem. Mol. Morphol. |volume=25 |issue=2 |pages=134–138 |date=February 2017 |pmid=26574638 |doi=10.1097/PAI.0000000000000279 |url=}}</ref> | ||
==Negative== | ==Negative== | ||
Revision as of 17:10, 25 March 2021
Hepatocyte nuclear factor-1beta, abbreviated HNF-1beta and HNF-1β, is an immunostain that marks clear cell carcinoma of the ovary.
Positive
Negative
References
- ↑ Hanley KZ, Cohen C, Osunkoya AO (February 2017). "Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall". Appl. Immunohistochem. Mol. Morphol. 25 (2): 134–138. doi:10.1097/PAI.0000000000000279. PMID 26574638.